Managing Potential Drug Interactions of Nirmatrelvir/Ritonavir in COVID-19 Patients: A Perspective from an Israeli Cross-Sector Collaboration

Clin Pharmacol Ther. 2022 Dec;112(6):1156-1158. doi: 10.1002/cpt.2610. Epub 2022 May 5.
No abstract available

MeSH terms

  • COVID-19 Drug Treatment*
  • Drug Interactions
  • Humans
  • Israel / epidemiology
  • Ritonavir* / therapeutic use

Substances

  • Ritonavir